Table of contents
April 2006 Volume 2 No 4
Top of page
Editorial
Top of page
Viewpoints
Are there differences in the renal effects of selective cyclo-oxygenase 2 inhibitors?
174Top of pageHome-based treatment of Fabry disease with
181
Research Highlights
Proteinuria detected in men following sexual intercourse might be misleading
178Intermittent saline flushes during hemodialysis do not reduce risk of coagulation
178Iodinated contrast agents do not accelerate residual renal function decline in PD patients
178Pediatric renal transplant recipients should be monitored for bladder dysfunction
179No effect of peritoneal dialysis on markers of cardiac function in renal failure
179Slowing the progression of renal disease with allopurinol
180High-flux dialysis might reduce cerebrovascular deaths in long-term hemodialysis patients
180High BMI is a modifiable risk factor for end-stage renal disease
180Adjustment of serum creatinine values should be standardized in MDRD calculations
181Home-based treatment of Fabry disease with 
-galactosidase A
181Pamidronate for steroid-induced osteoporosis in pediatric nephropathy patients
182Excellent kidney transplant outcomes for children with mental retardation
182CNI-free immunosuppression decreases the risk of malignancy after renal transplantation
183Top of page
Practice Points
Which factors are associated with failure of arteriovenous fistulas in hemodialysis patients?
184Can a 1-h peritoneal equilibration test accurately assess free water transport in peritoneal dialysis patients?
186What effects do hemodilution and blood transfusion during cardiopulmonary bypass have on renal outcomes?
188Correlation of change in serum creatinine levels 30 days after renal transplantation with long-term graft survival
190Does losartan alter urinary levels of connective tissue growth factor in patients with diabetic nephropathy?
192Risk and detection of renal scarring following acute pyelonephritis in children over 5 years
194Top of page
Reviews
Primary aldosteronism: diagnostic and treatment strategies
198doi:10.1038/ncpneph0151 | Full Text | PDF (271K)
Arginine, arginine analogs and nitric oxide production in chronic kidney disease
209doi:10.1038/ncpneph0143 | Full Text | PDF (294K)
Drug Insight: rituximab in renal disease and transplantation
221doi:10.1038/ncpneph0133 | Full Text | PDF (235K)
